Medicine News and Research

RSS

Child abuse can affect brain functions later life: Study

According to a new research from Yale University, teenagers who were abused as young children show changes in their brains that put them at risk for behavioral problems in adulthood.

6 Dec 2011

Roundup: Calif. to drop hospital report cards; Getting a doctor in N.Y. may depend on your neighborhood

The project was considered a pioneering effort when it started in 2004, but Jan Emerson-Shea, a spokesperson for the California Hospital Association, says the report cards have outlived their usefulness. "Today there are numerous places consumers can get information on the quality of care delivered by hospitals," Emerson-Shea says.

6 Dec 2011

Tips to keep kids safe during cold-weather

Cold winds, icy rain and, in some places, snow—Old Man Winter has arrived. His entry reminds us to get our furnaces checked and winterize our car, but what about the kids? "Children are even more vulnerable than adults to cold-weather and winter-related injuries," said Dr. Karen Judy, pediatrician at Loyola University Health System and professor of pediatrics at Loyola University Chicago Stritch School of Medicine.

6 Dec 2011

New research suggests that teenage texting of nude photos not so popular

Only 1 percent of kids aged 10 to 17 have shared images of themselves or others that involve explicit nudity, a nationally representative study found. Roughly the same number said they'd shared suggestive but less graphic photos; while 7 percent said they'd received either type of picture.

6 Dec 2011

Acupuncture for chemotherapy-induced peripheral neuropathy

Acupuncture may help ease the severe nerve pain associated with certain cancer drugs, suggests a small preliminary study published in Acupuncture in Medicine.

5 Dec 2011

EnVivo presents positive EVP-6124 Phase 2b trial data on schizophrenia at 50th ACNP meeting

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.

5 Dec 2011

Viewpoints: Premium support disadvantages; GOP candidates & the individual mandate; Stop fight over high court recusals?

Republican politicians are touting the virtues of market competition and calling for a "premium support" plan that would give beneficiaries a set amount of money to shop among private plans for their own insurance. What they do not say is that private plans have long been more costly than traditional Medicare and have shown far less ability to slow spending.

5 Dec 2011

Fatal snakebites emerging global threat

Fatal snakebites are a bigger-than-acknowledged global health problem that has been vastly under-reported, according to research presented today at the American Society of Tropical Medicine and Hygiene’s (ASTMH) annual meeting.

5 Dec 2011

Stem cells for the damaged heart

Stem cell research got its latest boost. For the first time, stem cells were injected into the hearts of humans who had suffered serious heart damage, and patients improved dramatically. The scientists found that the stem cells grew into new heart cells to replace the damaged tissue.

5 Dec 2011

Growth hormone PDGF-BB and blood protein EPO implicated in development of cancer

Researchers at the Swedish medical university Karolinska Institutet have demonstrated that a growth hormone, PDGF-BB, and the blood protein EPO are involved in the development of cancer tumours and that they combine to help the tumours proliferate in the body.

5 Dec 2011

Targacept commences two clinical studies of TC-5619 for schizophrenia and ADHD

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.

5 Dec 2011

Review highlights importance of examining totality of evidence prior to use of CPRs in clinical practice

Research carried out by the HRB Centre for Primary Care Research, based in the Royal College of Surgeons in Ireland (RCSI), recently published in the journal Family Practice aims to help patients that have suffered a transient ischaemic attack (TIA), otherwise known as a "mini-stroke" by assessing their risk of subsequent stroke.

5 Dec 2011

Beyond Lucid Technologies launches MediView software platform

Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.

5 Dec 2011

Concord Medical hosts Twelfth Annual CCM Academic Conference in Beijing

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it hosted the Twelfth Annual CCM Academic Conference in Beijing on December 3 and 4, 2011.

5 Dec 2011

Study shows new biochemical disturbances in the brains of children with ADHD

A new study at örebro University in Sweden shows that children with ADHD have nearly 50 percent less of a protein that is important for attention and learning. The finding may mean that there are other biochemical disturbances in the brains of individuals with ADHD than was previously believed.

5 Dec 2011

CPEB4 protein plays a crucial role in cancer progression

A study by researchers Ra-l M-ndez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona) and Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) describes a new reprogramming mechanism for the expression of genes responsible for turning a healthy cell into a tumor cell.

5 Dec 2011

American Society of Hematology 2012 Scholar Awards announced

The American Society of Hematology (ASH) announces the recipients of its 2012 Scholar Awards. The ASH Scholar Awards provide monetary support for fellows and junior faculty pursuing research careers to assist them during the critical period in which they must complete their training and achieve status as an independent investigator.

3 Dec 2011

Viewpoints: Is Berwick a scapegoat?; Rep. Smith on Kagan; Daschle on health IT

Don Berwick, the prominent pediatrician and Harvard School of Public Health professor who headed the Centers for Medicare and Medicaid Services, has officially stepped down, another victim of Washington's hyper-partisan politics.

3 Dec 2011

CDER, Shire enter agreement for ProAmatine clinical trial to treat symptomatic orthostatic hypotension

Shire plc, the global specialty biopharmaceutical company, announces that it has reached an agreement with the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration to conduct additional clinical trials to confirm the clinical benefit of ProAmatine (midodrine HCl), a medicine approved in 1996 under Subpart H for the treatment of symptomatic orthostatic hypotension (SOH).

3 Dec 2011

Research roundup: Recession's big impact on men's insurance coverage

Researchers examined three sets of surveillance data and found that of the estimated 1.2 million persons in the United States living with the human immunodeficiency virus, 942,000 persons were aware of their infection. More than three-quarters of those were "linked to care" and among HIV-infected adults in care, "45 percent received prevention counseling, and 89 percent were prescribed antiretroviral therapy."

3 Dec 2011